Peng, Xudong
Tang, Gang
Wang, Yonghong
Zeng, Fanling
Chen, Yuedong
Zhang, Weidan
Mo, Chunmei
Yang, Yana
Li, Shuang
Bai, Lian
Xiao, Dachun
Zheng, Guolian
Ran, Wenhua
Chen, Cheng
Yang, Yonghong
Gao, Yuanze
Zhu, Shuangwei
Huang, Zheng
Zhao, Dongqing
Wu, Chaofeng
Xu, Li
Wei, Zhengqiang
Funding for this research was provided by:
Chongqing key diseases Research and Application Demonstration Program from Chongqing Municipal Health Commission (No. 2019ZX003)
Article History
Received: 14 May 2023
Accepted: 6 December 2023
First Online: 18 December 2023
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki and approved by the ethics committee of the First Affiliated Hospital of Chongqing Medical University. An electronic informed consent form appeared when participants started the risk assessment on ESA, informing them of the screening purpose, the process and the privacy terms. All subjects in the ESA group signed electronic informed consent. Since there were no additional interventions for the control group, the study was approved by the ethics committee of the First Affiliated Hospital of Chongqing Medical University for an exemption from requiring informed consent from the control group.
: Not Applicable.
: The authors declare no competing interests.